drugset
drugset / Trial / NCT01740986

Safety and Efficacy of SA09012 in Asthma

NCT01740986 ↗

Phase 2 Completed 225 enrolled SamA Pharmaceutical Co., Ltd
RandomizedParallel-groupTriple-blindTreatment

Summary

Clinical Study to Evaluate the Efficacy, Dose-response and Safety of SA09012 in Bronchial Asthma Patients

Timeline

Start
2012-11
Primary completion
2015-07
Completion
2015-11

Drugs

EvaluationDrugModalityDoseRoute
Subject SA09012 Unknown — —

Indications

asthma